• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ossification (1428); Dysphagia/ Odynophagia (1815); Inflammation (1932); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Respiratory Distress (2045); Weakness (2145); Osteolysis (2377); No Code Available (3191)
Event Type  Injury  
Event Description
It was reported that the patient underwent an anterior cervical discectomy and fusion using rhbmp-2/acs.The patient's post-operative period was marked by severe pain.Following the surgery the patient suffered from autonomic neuropathy, small fiber neuropathy, peripheral neuropathy, muscle atrophy and nerve damage, inflammatory reactions, chronic radiculitis, sterility, osteolysis (bone resorption), displacement or migration of the spacer cage, pseudoarthrosis, dysphagia, difficulty breathing, difficulty gripping and holding items, and chronic pain.The patient now suffers from bone overgrowth causing nerve compression, chronic pain and radiculitis, and emotional distress and mental anguish.
 
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Manufacturer Narrative
 
Event Description
It was reported that the patient underwent an anterior cervical discectomy fusion procedure at c3-6 using rhbmp-2/acs.The patient's post-operative period was marked by an acute inflammatory reaction.
 
Event Description
It was reported that on (b)(6) 2009: the patient presented with cervical pain.Cervical radiculopathy.Cervical disk herniation at c3-4, c4-5 and c5-6.The patient underwent the following procedures: anterior cervical discectomy at c3-4, c4-5 and c5-6, approached from the patient's right side.Structural allograft fusion c3-4, c4-5, and c5-6.Arthrodesis c3-4, c4-5, and c5-6.Anterior cervical plating c3-c6, bone morphogenic protein.Placement of philadelphia collar.The post-op diagnosis: cervical pain.Cervical radiculopathy.Cervical disk herniation at c3-4, c4-5 and c5-6.Cervical instability.Bony foraminal stenosis c5-6 bilaterally.As per-op notes, "the c4-5 disk space was identified using fluoroscopy.Diskectomy was performed at c4-5.Identical procedure was performed at c5-6 and at c3-4.All the levels required drilling to remove the remainder of the disk material and to prepare the endplates for fusion.The posterior longitudinal ligament at c3-4 and c5-6 both had been violated by extruded disk fragments, which were removed.At c3-4, there was some bony osteophytic component but the largest component of the compression of the spinal cord was the disk fragment that herniated.The bony osteophytic components as well as soft tissue components were removed.Identical procedures were performed at c4-5 and c5-6.Once all the three levels were decompressed, they were irrigated and hemostasis was achieved.A small 2 to 4 mm fragment of rhbmp-2/acs was placed in the small circular space of each of the bone grafts, and that was placed at each level.Once the 6 mm bony structural allografts were placed at each level, they were tamped into place, and the cervical traction was removed."no patient complications were reported.On (b)(6) 2009: the patient was discharged.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
huzefa mamoola
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key3661568
MDR Text Key4316529
Report Number1030489-2014-01313
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup,Followup
Report Date 06/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2012
Device Catalogue Number7510200
Device Lot NumberM110805AAB
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received06/14/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/24/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-